In conclusion, this study has demonstrated a modestly increased risk of premenopausal breast cancer in women harboring the LEPR 223Arg allele of the LEPR Gln223Arg polymorphism of the leptin receptor gene. This evidence concerns the gene LEPR and breast carcinoma.